FindTrial
Sign In

Clinical outcomes of head and neck cancers treated with radical intent

Clinical outcomes of head and neck cancers comprehensively treated with radical intent at HBCHRC Vishakhapatnam- A Retrospective Analysis - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/076093
Enrollment
600
Registered
2024-10-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Homi Bhabha Cancer Hospital and Research Center, Tata Memorial Centre, Visakhapatnam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All head and neck cancer patient comprehensively (received entire treatment in HBCH&RC) treated with radical intent at HBCH&RC

Exclusion criteria

Exclusion criteria: 1. Received at least one radical intent of treatment outside HBCH&RC 2. Treated with palliative intent

Design outcomes

Primary

MeasureTime frame
To assess clinico-epidemiological profile and outcomes of head and neck cancer patients comprehensively treated with radical intent at HBCHRC VishakhapatnamTimepoint: 2 years—

Secondary

MeasureTime frame
To assess the locoregional control (LRC)Timepoint: 2years;To assess disease free survival (DFS)Timepoint: 2years;To assess Overall survival (OS)Timepoint: 2years;To assess p16 positivity by IHCTimepoint: 2years;To assess acute & late toxicitiesTimepoint: 2years;To find out prognostic factors associated with LRC, DFS & OSTimepoint: 2years—

Countries

India

Contacts

Public ContactDr Rohit Avinash Vadgaonkar

Homi Bhabha Cancer Hospital and Research Center

dr.ravad@gmail.com917973783256

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026